The treatment of community-acquired pneumonia (CAP) in children is empirical, being
based on the knowledge of the etiology of CAP at different ages. As a result of currently …

Objectives: To evaluate adherence to guidelines for inpatient care of pediatric patients with
community-acquired pneumonia (CAP). Background: Pediatric CAP is one of the most …

Community‐acquired pneumonia (CAP) still remains a significant cause for childhood
morbidity worldwide. Streptococcus pneumoniae is the most important causative agent at all …

Pneumonia is a common pediatric infectious disease that is familiar to pediatricians and a
major cause of hospitalization worldwide. Recent well-designed epidemiologic studies in …

Pneumonia is the leading cause of death in children under 5 years of age worldwide and a
cause of morbidity in a considerable number of children. A number of studies have sought to …

Community-acquired pneumonia (CAP) is a significant cause of childhood morbidity and
mortality worldwide. Viral etiology is most common in young children and decreases with …

Community-acquired pneumonia (CAP) remains a frequent cause of morbidity and mortality
worldwide even in industrialised countries, and its incidence is highest among children …

Introduction: Community-acquired pneumonia (CAP) is the leading cause of mortality among
children under 5 years worldwide. However, the choices of chemical therapy for the …

Community-acquired pneumonia (CAP) is a common cause of morbidity among children in
developed countries and accounts for an incidence of 10-40 cases per 1000 children in the …

Background: Community-acquired pneumonia is an important cause of morbidity in
developed countries and an important cause of morbidity and mortality in developing …